KEY ARCHIVE FOR
THE PAST 8-12
WEEKS
HYPERTENSION
DIALYSIS-CRF
CLINICAL NEPHR
FOR NURSES
FREE ZONE
KEY ZONE
SEARCH FOR A TALK
May 6, 2020
ISHD Hemodialysis University 2019
International Society for Hemodialysis (Chicago, IL; September, 2019)  

PART 3

Magnesium Balance During Hemodialysis - Can We Do Better?
David J. Leehey, MD

Recovery of Renal Function after Starting Dialysis
William Luke Whittier, MD

Hypertension in Dialysis Patients
Rajiv L. Agarwal, MD

Treatment of Severe Hyponatremia by CRRT and Hemodialysis
Jerry Yee, MD

Advances in Chronic Kidney Disease 2019
Renal Research Institute (New Orleanas; January, 2019)  

PART 8

How Metabolomics is bound to make an impact in Nephrology?
Nadja Grobe, MD

Dialysate Sodium Levels - Should we care?
Finnian Mc Causland, MD

Harvard Intensive Review of Nephrology 2018
Brigham and Women's Hospital Department of Medicine (Boston, MA; August, 2018)  

PART 8

Donor Evaluation
David Wojciechowski DO



WILEY PUBLISHING, publishers of many journals and books of interest to kidney disease professionals, including the journals Am J Transplantation, Seminars in Dialysis, and Hemodialysis International.
For more information about Wiley Publishing please visit
http://www.wiley.com/WileyCDA/Section/id-351440.html

 


2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabet Care)
Time to include nonalcoholic steatohepatitis (Diabet Care)
Empagliflozin effectively lowers liver fat content in well- controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo- controlled trial (Diabet Care)
Reinterpreting cardiorenal protection of renal sodium-glucose cotransporter 2 inhibitors via cellular life history programming (Diabet Care)
SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mech. of action (Diabet Care)
Association of blood pressure with outcomes in acute stroke thrombectomy (Hypertens)
Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries (Am J Clin Nutr)
Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus. insights from the DECLARE-TIMI 58 trial (Circulation)
Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in U.K. Biobank (Diabet Care)
Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit (Hypertens)
Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension (JAMA Intern Med)
Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE) (Diabet Care)
Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemiatwo randomized clinical trials (J Am Med Assoc)
Ultrafiltration rate, residual kidney function, and survival among patients treated with reduced-frequency hemodialysis (Am J Kidney Dis)
A simple tourniquet technique for bleeding control after percutaneous hemodialysis fistula and graft interventions (BMC Nephrol)
10-year-long survival in a PD patient with severe calcifying encapsulating peritoneal sclerosis treated with tamoxifen: a case-report (BMC Nephrol)
High dose haemodialysis and haemodiafiltrationadvanced vascular calcification (BMC Nephrol)
Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges (BMC Nephrol)
Itch and ache on dialysis: new approaches to manage uremic pruritus and restless legs (Blood Purif)
First-in-human experience with peritoneal direct sodium removal using a zero-sodium solution. A new candidate therapy for volume overload (Circulation)
Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis. results of a randomized phase 2b study (Circulation)
Proton pump inhibitors and the kidney: implications of current evidence for clinical practice and when and how to deprescribe (Am J Kidney Dis)
KDOQI clinical practice guideline for vascular access: 2019 update (Am J Kidney Dis)
Association between extracellular volume control and survival in patients on short daily haemodialysis (BMC Nephrol)
Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease (Circulation)
The low-protein diet for chronic kidney disease: 8 years of clinical experience in a nephrology ward (Clin Kidney J)
A new technique for measuring fistula flow using venous blood gas oxygen saturation in patients with a central venous catheter (Clin Kidney J)
Retraction and replacement of a report on dialysis ownership and access to kidney transplantation (J Am Med Assoc)
Management of coronary disease in patients with advanced kidney disease (N Engl J Med)
Joint association of vitamins D and K status with long-term outcomes in stable kidney transplant recipients (Nephrol Dial Transplant)
Serum magnesium, mortality and disease progression in chronic kidney disease (BMC Nephrol)
Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease (Clin J Am Soc Nephrol)
Aliskiren as an adjunct therapy for atypical hemolytic uremic syndrome (Clin Kidney J)
Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replacement therapy: 30-year follow-up of a nationwide cohort (Diabet Care)
Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group ii gadolinium-based contrast agents: a systematic review and meta-analysis (JAMA Intern Med)
Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis (N Engl J Med)
KDOQI US commentary on the 2017 KDIGO Clinical practice guideline on the evaluation and care of living kidney donors (Am J Kidney Dis)
How should we manage renal transplant patients with failed allografts who return to dialysis? (Blood Purif)
Urea for chronic hyponatremia (Blood Purif)
A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis (J Am Soc Nephrol)


 2019
 

 H: Exam and lab tests -- Arm cuff
Hypertension Is Associated with Adverse Cardiovascular Outcomes Only When Both Brachial and Central Blood Pressures Are Elevated
 H: Special problems -- Outcomes
Blood Pressure Lowering for the Prevention of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis
 H: Special problems -- Obesity, Insulin Resistance
Life's Simple 7 and Risk of Cardiovascular Disease in the Chronic Renal Insufficiency Cohort

 Basic hemodialysis -- Heparinization/anticoagulation
Effect of Aspirin on Cardiovascular Events, Mortality, and Bleeding Outcomes in Older Individuals with CKD
 Basic hemodialysis -- Adequacy, prescription, urea kinetics
A 24-Month Interim Analysis of a Phase 2 Trial Evaluating the Long-Term Efficacy and Safety of Oxabact OC5 in Dialysis Patients with Primary Hyperoxaluria Type 1 (PH1)
 Basic hemodialysis -- Complications (acute)
The Impact of Eating During Hemodialysis Treatment on Nutritional Measures in In-Center Hemodialysis Patients
 Basic hemodialysis -- Continuous therapies
Potential Adverse Hemodynamic Effects of Higher-Intensity Continuous Renal Replacement Therapy
 CRF by problem area -- Etiology
Progressive Kidney Failure: An Overlooked Feature of Down Syndrome
 CRF by problem area -- Progression
Attenuation of Estimated Glomerular Filtration Rate Decline After Arteriovenous Fistula Creation in Pre-Dialysis
Aldosterone Antagonists for Preventing the Progression of CKD: An Updated Cochrane Review
Effect of Bardoxolone Methyl on Kidney Events in Patients with CKD Stage 4 and Type 2 Diabetes at High Risk of Adverse Kidney Outcomes
The Effect of Proton Pump Inhibitor Use on the Development of Metabolic Acidosis and Decline in Kidney Function in Patients with CKD Stages G3a to G4
 CRF by problem area -- Bone disease/Ca-P/PTH
PiT-2 Is the Main Transporter Responsible for Intestinal Phosphate Absorption in Human
Increase in Fat Mass Has Protective Effect on Bone Mineral Density Loss After Initiation of Dialysis Therapy
The Effect of Increasing Dialysate Magnesium on Calciprotein Particles, Inflammation, and Bone Markers in Subjects with ESKD: Post Hoc Analyses from a Randomized Controlled Trial
Bisphosphonate Utilization Across the eGFR Spectrum
PTH Levels Prior to Initiating Hemodialysis: Associations with Prescription of PTH-Lowering Therapies and Risk of Uncontrolled PTH During the First Year of Hemodialysis
Parathyroidectomy vs. Cinacalcet for Secondary Hyperparathyroidism in Patients Undergoing Hemodialysis
EOS789, a Novel Pan-Inhibitor of NaPi-IIb/PiT-1/PiT-2, Suppressed Intestinal Phosphate Absorption in Healthy Subjects: A Phase 1 Clinical Trial
Spurious Hyperphosphatemia in Patients with ESRD on Hemodialysis
 CRF by problem area -- CRF and diabetes
Advanced CKD Is Associated with Higher and Not Lower Insulin Use
Efficacy and Safety of Low-Dose Metformin for Improving Glycemic Control in Type 2 Diabetic Patients Receiving Maintenance Hemodialysis (HD): An Assessment by Continuous Glucose Monitoring (CGM)
Metformin Use Is Associated with Asymptomatic Hyperlactatemia in Elderly Diabetic Men with Stage 3 CKD
 CRF by problem area -- CRF in infants and children
A Pilot Study of a Gluten-Free Dairy-Free Dietary Intervention in Children with Steroid-Resistant Nephrotic Syndrome
 CRF by organ system -- Cardiovascular/Hypertension
Effect of Warfarin on Progression of Vascular Calcification
 CRF by organ system -- GI/Liver, Hepatitis
Impact of Elobixibat on Chronic Constipation in Patients on Hemodialysis Assessed Using the Patient Assessment of Constipation-Quality of Life Questionnaire
 CRF by organ system -- CRF in Women
Contraceptive Use and Elective Terminations in Women with Glomerular Disease
Contraceptive Use Among Women with ESKD on Dialysis in the United States
 CRF by organ system -- Neurological
Benzodiazepines, Opioids, and Mortality Among Hemodialysis Patients
 CRF by organ system -- Endocrine
Levothyroxine in Proteinuric CKD Patients Decreases Proteinuria and Improves Kidney Function: A Randomized, Double-Blind, Clinical Trial
Testosterone Replacement Therapy (TRT) Delays Early Progression of CKD in Diabetes Mellitus (DM2)

 Assessing renal function -- Creatinine clearance
eGFR Trajectory in Old Age
The Difference Between eGFR by Cystatin C vs. Creatinine Provides Clinical Information About Frailty in SPRINT
Validation of Different Serum Creatinine-Based Estimating Equations in Pediatric Kidney Transplant Recipients in Comparison with Measured Glomerular Filtration Rate
 Acid-base/Lytes -- Metabolic acidosis
Differences in Urinary Potassium and Acid-Base Handling in African American vs. Non-African American CKD Patients
Randomized Controlled Trial of Long-Term Safety and Efficacy of Veverimer for Treatment of Metabolic Acidosis
 Acid-base/Lytes -- Hyperkalemia
Patiromer Treatment of Hyperkalemia in Adolescent Children with CKD: Initial Results from EMERALD
Patiromer Controls Serum Potassium for Up to 1 Year in Hyperkalemic Patients with Diabetes and Advanced Kidney Disease on RAAS Inhibitors Regardless of Age
 Acid-base/Lytes -- Hypomagnesemia
Effect of Hypomagnesemia on Vascular Calcification in Peritoneal Dialysis Patients
 ARF etiology -- Radiocontrast media
Effect of Remote Ischemic Preconditioning to Prevent AKI in CKD Patients Undergoing Contrast-Enhanced Computed Tomography: A Randomized Controlled Trial
 Proteinuria/Hematuria -- Focal, collapsing GN
Incremental Reduction of Proteinuria and Kidney Survival in FSGS
 Proteinuria/Hematuria -- IgA Nephropathy
Genetic Polymorphism in C3 Is Associated with CKD Progression in IgA Nephropathy
The Association of Hematuria with MEST-C Score and Renal Outcomes in IgA Nephropathy
 Cystic disease -- Hereditary polycystic disease
Relationship of Tolvaptan Dose with the Rate of Decline in Kidney Function in ADPKD Patients
Differential Effects of Tolvaptan on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease Patients with PKD1 and PKD2 Mutations
High Salt Intake but Not High Protein Intake Leads to Increased Disease Progression in ADPKD
Serum Bicarbonate but Not Urine Ammonium Predicts Renal Outcomes in Polycystic Kidney Disease
 Transplant -- Transplantation
Survival Advantage of Renal Transplantation over Dialysis Is Blunted in Women

ADVERTISEMENT